Govindarajan Koushik A, Narayana Ponnada A, Hasan Khader M, Wilde Elisabeth A, Levin Harvey S, Hunter Jill V, Miller Emmy R, Patel Vipul Kumar S, Robertson Claudia S, McCarthy James J
1 Department of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston , Houston, Texas.
2 Department of Physical Medicine and Rehabilitation, Baylor College of Medicine , Houston, Texas.
J Neurotrauma. 2016 Oct 15;33(20):1809-1817. doi: 10.1089/neu.2015.4253. Epub 2016 Mar 9.
Magnetic resonance imaging data were acquired at ∼24 h and ∼3 months post-injury on mild traumatic brain injury (mTBI; n = 75) and orthopedic injury (n = 60) cohorts. The mTBI subjects were randomly assigned to a treatment group with atorvastatin or a non-treatment mTBI group. The treatment group was further divided into drug and placebo subgroups. FreeSurfer software package was used to compute cortical thickness based on the three dimensional T1-weighted images at both time-points. Cross-sectional analysis was carried out to compare cortical thickness between the mTBI and control groups. Longitudinal unbiased templates were generated for all subjects and cortical thickness measurements were compared between baseline and follow-up scans in the mTBI group. At baseline, significant reduction in cortical thickness was observed in the left middle temporal and the right superior parietal regions in the mTBI group, relative to the control group (p = 0.01). At follow-up, significant cortical thinning was again observed in the left middle temporal cortex in the mTBI group. Further analysis revealed significant cortical thinning only in the non-treatment group relative to the control group. In the follow-up, small regions with significant but subtle cortical thinning and thickening were seen in the frontal, temporal, and parietal lobes in the left hemisphere in the non-treatment group only. Our results indicate that cortical thickness could serve as a useful measure in identifying subtle changes in mTBI patients.
在轻度创伤性脑损伤(mTBI;n = 75)和骨科损伤(n = 60)队列中,分别在损伤后约24小时和3个月时采集磁共振成像数据。mTBI受试者被随机分为阿托伐他汀治疗组或mTBI非治疗组。治疗组进一步分为药物亚组和安慰剂亚组。使用FreeSurfer软件包根据两个时间点的三维T1加权图像计算皮质厚度。进行横断面分析以比较mTBI组和对照组之间的皮质厚度。为所有受试者生成纵向无偏模板,并比较mTBI组基线扫描和随访扫描之间的皮质厚度测量值。在基线时,与对照组相比,mTBI组左侧颞中回和右侧顶上小叶区域的皮质厚度显著降低(p = 0.01)。在随访时,mTBI组左侧颞中回皮质再次出现显著变薄。进一步分析显示,相对于对照组,仅在非治疗组中观察到显著的皮质变薄。在随访中,仅在非治疗组的左半球额叶、颞叶和顶叶中发现了有显著但细微的皮质变薄和增厚的小区域。我们的结果表明,皮质厚度可作为识别mTBI患者细微变化的有用指标。